Several risk factors associated with the development of severe disease in pediatric patients with COVID-19 have been described, including age (under 5 years and adolescents); previous comorbidities; symptoms of cough, dyspnea and fever on admission; and lymphopenia, elevated CRP and LDH [34,35,42,43]. This evidence concerns the gene CRP and lymphopenia.